PR Newswire
SAN FRANCISCO, June 6, 2017
SAN FRANCISCO, June 6, 2017 /PRNewswire/ -- Nektar
Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at the upcoming Jefferies 2017 Global
Healthcare Conference in New York City on Wednesday, June 7, 2017
at 9:30 a.m. Eastern time.
The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the
Nektar website: http://ir.nektar.com/events.cfm.
This Webcast will be available for replay until July 10, 2017.
About Nektar
Nektar Therapeutics is a research-based development stage biopharmaceutical company whose mission is to discover and
develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational
medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar's proprietary and proven
chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco,
California, with additional operations in Huntsville, Alabama and Hyderabad,
India. Further information about the company and its drug development programs and capabilities
may be found online at http://www.nektar.com.
Contact:
Investors
Jennifer Ruddock of Nektar Therapeutics
415-482-5585
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nektar-to-webcast-presentation-at-jefferies-2017-global-healthcare-conference-in-new-york-city-300469746.html
SOURCE Nektar Therapeutics